maintenance tirzepatide Hub Tirzepatide Injections for Medical Weight

This rapid access is particularly beneficial for those seeking timely prescriptions like Semaglutide

Some are exaggerated

For weight management (Wegovy / Mounjaro) EMA and Irish prescribing guidance currently restricts weight-loss GLP-1s to adults with (see our full eligibility guide): BMI 30 kg/m (obesity), or BMI 27 kg/m (overweight) plus at least one weight-related condition type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or established cardiovascular disease You should also be willing to engage with lifestyle change (diet and physical activity) these medicines are an addition to, not a replacement for, behaviour change

Also, 93.5% of the people who took GLP-1s survived during the five-year follow-up, versus 85.7% of those who didnt take GLP-1s